Table 5 The adjusted hazard ratio (aHR) of patient demographics and comorbidities associated with recurrence of BCC.
From: Different histopathologic profiles and outcomes between sun-exposed BCC and non-sun-exposed BCC
Recurrence (%) | Non-recurrence (%) | HR (95% CI) | p-value | aHR (95% CI) | p-value | ||
|---|---|---|---|---|---|---|---|
Age of index lesion | <65.0 | 5 (29.4) | 93 (24.1) | 1 [Reference] | |||
65.0–74.99 | 4 (23.5) | 96 (24.9) | 0.77 (0.21–2.89) | 0.703 | 0.43 (0.05–3.37) | 0.419 | |
>= 75.0 | 8 (47.1) | 197 (51.0) | 1.30 (0.40–4.22) | 0.659 | 0.39 (0.08–2.06) | 0.269 | |
Sex (men) | 11 (64.7) | 242 (62.7) | 0.91 (0.33–2.46) | 0.845 | 0.99 (0.26–3.80) | 0.991 | |
DM | 5 (29.4) | 99 (25.6) | 1.38 (0.48–3.93) | 0.548 | 0.45 (0.07–2.77) | 0.391 | |
HT | 10 (58.8) | 178 (46.1) | 1.91 (0.72–5.08) | 0.194 | 3.07 (0.70–13.46) | 0.137 | |
ESRD | 2 (11.8) | 12 (3.1) | 4.63 (1.04–20.66) | 0.045 | 1.55 (0.10–23.36) | 0.751 | |
Infiltrating or mixed-infiltrating subtype | 2 (16.7) | 11 (4.2) | 3.20 (0.62–16.47) | 0.165 | 6.17 (1.07–35.64) | 0.042 | |
Synchronous basosquamous cell carcinoma | 2 (11.8) | 4 (1.0) | 12.01 (2.66–54.50) | 0.001 | 16.84 (1.31–216.92) | 0.030 | |
